SE0102069D0 - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation

Info

Publication number
SE0102069D0
SE0102069D0 SE0102069A SE0102069A SE0102069D0 SE 0102069 D0 SE0102069 D0 SE 0102069D0 SE 0102069 A SE0102069 A SE 0102069A SE 0102069 A SE0102069 A SE 0102069A SE 0102069 D0 SE0102069 D0 SE 0102069D0
Authority
SE
Sweden
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Application number
SE0102069A
Other languages
English (en)
Inventor
Khoo Cynthia Gaik-Lim
Helena Gustafsson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0102069A priority Critical patent/SE0102069D0/sv
Publication of SE0102069D0 publication Critical patent/SE0102069D0/sv
Priority to ARP020102278A priority patent/AR034517A1/es
Priority to RU2003136155/15A priority patent/RU2323006C2/ru
Priority to MXPA03011546A priority patent/MXPA03011546A/es
Priority to SK1591-2003A priority patent/SK286238B6/sk
Priority to IL15921702A priority patent/IL159217A0/xx
Priority to BR0210489-0A priority patent/BR0210489A/pt
Priority to US10/481,232 priority patent/US7700582B2/en
Priority to AT02744027T priority patent/ATE314093T1/de
Priority to CNA028125347A priority patent/CN1518462A/zh
Priority to DE60208369T priority patent/DE60208369T2/de
Priority to CZ20033491A priority patent/CZ299859B6/cs
Priority to SI200230264T priority patent/SI1401502T1/sl
Priority to MYPI20022304A priority patent/MY130332A/en
Priority to NZ530086A priority patent/NZ530086A/en
Priority to DK02744027T priority patent/DK1401502T3/da
Priority to PL02366432A priority patent/PL366432A1/xx
Priority to KR10-2003-7016620A priority patent/KR20040011542A/ko
Priority to PCT/SE2002/001217 priority patent/WO2003000293A1/en
Priority to EEP200400028A priority patent/EE200400028A/xx
Priority to UA20031211097A priority patent/UA77959C2/uk
Priority to CA002450449A priority patent/CA2450449A1/en
Priority to JP2003506935A priority patent/JP2005501024A/ja
Priority to ES02744027T priority patent/ES2254699T3/es
Priority to AU2002345463A priority patent/AU2002345463B2/en
Priority to HU0400850A priority patent/HUP0400850A3/hu
Priority to EP02744027A priority patent/EP1401502B1/en
Priority to UY27345A priority patent/UY27345A1/es
Priority to SA02230168A priority patent/SA02230168B1/ar
Priority to ZA200309316A priority patent/ZA200309316B/en
Priority to IL159217A priority patent/IL159217A/en
Priority to NO20035627A priority patent/NO20035627D0/no
Priority to IS7081A priority patent/IS2347B/is
Priority to CO03110716A priority patent/CO5550466A2/es
Priority to BG108516A priority patent/BG108516A/xx

Links

SE0102069A 2001-06-21 2001-06-21 Pharmaceutical formulation SE0102069D0 (sv)

Priority Applications (35)

Application Number Priority Date Filing Date Title
SE0102069A SE0102069D0 (sv) 2001-06-21 2001-06-21 Pharmaceutical formulation
ARP020102278A AR034517A1 (es) 2001-06-21 2002-06-18 Formulacion farmaceutica
EP02744027A EP1401502B1 (en) 2001-06-21 2002-06-19 Pharmaceutical formulation comprising iota-carrageenan and at least one neutral gelling polymer
PL02366432A PL366432A1 (en) 2001-06-21 2002-06-19 Pharmaceutical formulation
EEP200400028A EE200400028A (et) 2001-06-21 2002-06-19 Ravimpreparaat, selle valmistamise meetod ja selle kasutamine meditsiinis
SK1591-2003A SK286238B6 (sk) 2001-06-21 2002-06-19 Farmaceutická formulácia obsahujúca iota-karagenan a spôsob jej prípravy
IL15921702A IL159217A0 (en) 2001-06-21 2002-06-19 An oral pharmaceutical formulation comprising a basic pharmaceutically active ingredient having ph-dependent solubility, a process for the manufacture thereof and use thereof in medicine
BR0210489-0A BR0210489A (pt) 2001-06-21 2002-06-19 Formulação farmacêutica oral, processo para preparar a mesma, uso da mesa, e método para preparar um distúrbio cardiovascular em um paciente
US10/481,232 US7700582B2 (en) 2001-06-21 2002-06-19 Pharmaceutical formulation
AT02744027T ATE314093T1 (de) 2001-06-21 2002-06-19 Pharmazeutische formulierung enthaltend iota- carrageenan und mindestens ein gel-bildende neutrale polymer
CNA028125347A CN1518462A (zh) 2001-06-21 2002-06-19 药物制剂
DE60208369T DE60208369T2 (de) 2001-06-21 2002-06-19 Pharmazeutische Formulierung enthaltend IOTA-Carrageenan und mindestens ein Gel-Bildendes neutrales Polymer
CZ20033491A CZ299859B6 (cs) 2001-06-21 2002-06-19 Farmaceutická formulace a zpusob její prípravy
SI200230264T SI1401502T1 (sl) 2001-06-21 2002-06-19 Farmacevtska formulacija, ki obsega jota-karagenan in vsaj en nevtralni zelirni polimer
MYPI20022304A MY130332A (en) 2001-06-21 2002-06-19 Pharmaceutical formulation comprising iota-carrageenan and at least one neutral gelling polymer
NZ530086A NZ530086A (en) 2001-06-21 2002-06-19 Pharmaceutical formulation
DK02744027T DK1401502T3 (da) 2001-06-21 2002-06-19 Farmaceutisk formulering, der omfatter iota-carrageenan og mindst én neutral geldannende polymer
RU2003136155/15A RU2323006C2 (ru) 2001-06-21 2002-06-19 Фармацевтическая композиция
KR10-2003-7016620A KR20040011542A (ko) 2001-06-21 2002-06-19 제약 제제
PCT/SE2002/001217 WO2003000293A1 (en) 2001-06-21 2002-06-19 Pharmaceutical formulation
MXPA03011546A MXPA03011546A (es) 2001-06-21 2002-06-19 Formulacion farmaceutica.
UA20031211097A UA77959C2 (en) 2001-06-21 2002-06-19 Pharmaceutical formulation comprising iota-carrageenan and neutral gelling polymer, process for manufacture and use
CA002450449A CA2450449A1 (en) 2001-06-21 2002-06-19 Pharmaceutical formulation
JP2003506935A JP2005501024A (ja) 2001-06-21 2002-06-19 医薬製剤
ES02744027T ES2254699T3 (es) 2001-06-21 2002-06-19 Formulacion farmaceutica que comprende iota-carragenano y al menos un polimero gelificante neutro.
AU2002345463A AU2002345463B2 (en) 2001-06-21 2002-06-19 Pharmaceutical formulation
HU0400850A HUP0400850A3 (en) 2001-06-21 2002-06-19 Oral pharmaceutical compositions
UY27345A UY27345A1 (es) 2001-06-21 2002-06-21 Formulación farmacéutica.
SA02230168A SA02230168B1 (ar) 2001-06-21 2002-06-22 صيغة صيدلانية تشتمل على مركب أيوتا - كاراجينان iota-carrageenan وعلى الأقل بوليمر هلام gelling polymer متعادل واحد
ZA200309316A ZA200309316B (en) 2001-06-21 2003-11-28 Pharmaceutical formulation.
IL159217A IL159217A (en) 2001-06-21 2003-12-07 Oral pharmaceutical formulation containing a basic active pharmaceutical ingredient with pH-dependent solubility, process for its production and use in medicine
NO20035627A NO20035627D0 (no) 2001-06-21 2003-12-15 Farmasöytisk formulering
IS7081A IS2347B (is) 2001-06-21 2003-12-16 Lyfjablanda til inntöku um munn sem felur í sér jóta-karragen, eina eða fleiri hlutlausar hlaupkenndar fjölliður og basískan lyfjafræðilegan efnisþátt; þar sem blandan tálmar losun basíska lyfjafræðilega virka efnisþáttarins úr blöndunni við súrt pH-
CO03110716A CO5550466A2 (es) 2001-06-21 2003-12-18 Formulacion farmaceutica
BG108516A BG108516A (en) 2001-06-21 2004-01-06 Pharmaceutical formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0102069A SE0102069D0 (sv) 2001-06-21 2001-06-21 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
SE0102069D0 true SE0102069D0 (sv) 2001-06-21

Family

ID=20284443

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0102069A SE0102069D0 (sv) 2001-06-21 2001-06-21 Pharmaceutical formulation

Country Status (1)

Country Link
SE (1) SE0102069D0 (sv)

Similar Documents

Publication Publication Date Title
NO20033384L (no) Farmasoytisk formulering
NO20033785D0 (no) Farmasöytisk formulering
NO20033556L (no) Farmasöytiske formuleringer
ITTO20010008A0 (it) Formulazione farmaceutica
FI20011478A0 (sv) Farmaceutisk komposition
PT1501534E (pt) Formulacoes farmaceuticas
NO20035627D0 (no) Farmasöytisk formulering
IS7051A (is) Lyfjasamsetningar
DE50209245D1 (de) Neuroprotektives medikament
FI20022128A (sv) Farmaceutisk komposition
NO20042502L (no) Farmasoytisk formulering omfattende bicalutamid
NO20041485L (no) Farmasoytisk formulering omfattende (R)-bicalutamid
AR025867A1 (es) Formulacion portasdora farmaceutica
DE10291905D2 (de) Pharmazeutische Zusammensetzung
NO20015534D0 (no) Farmasöytisk blandeapparat
EE200300465A (et) Püridoindolooni derivaatidel põhinevad farmatseutilised kompositsioonid
DE10107261B4 (de) Pharmazeutische Zusammensetzung
NO20041236L (no) Farmasoytisk formulering
FI20012242A0 (sv) Nya farmaceutiska föreningar
SE0102957D0 (sv) Pharmaceutical formulation
SE0103565D0 (sv) Pharmaceutical formulation
SE0102572D0 (sv) Pharmaceutical formulation
SE0102069D0 (sv) Pharmaceutical formulation
SE0101326D0 (sv) Pharmaceutical formulation
SE0101325D0 (sv) Pharmaceutical formulation